Accelerate Diagnostics, Inc. (AXDX)
USD 0.64
(-7.51%)
USD 0.64
(-7.51%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 31.36 Million USD | -51.76% |
| 2022 | 65.01 Million USD | -21.71% |
| 2021 | 83.04 Million USD | -11.11% |
| 2020 | 93.42 Million USD | -30.5% |
| 2019 | 134.42 Million USD | -27.44% |
| 2018 | 185.26 Million USD | 46.19% |
| 2017 | 126.72 Million USD | 52.96% |
| 2016 | 82.85 Million USD | -40.53% |
| 2015 | 139.32 Million USD | 99.6% |
| 2014 | 69.8 Million USD | 60.72% |
| 2013 | 43.43 Million USD | 152.3% |
| 2012 | 17.21 Million USD | 174.79% |
| 2011 | 6.26 Million USD | -0.07% |
| 2010 | 6.26 Million USD | 19.83% |
| 2009 | 5.23 Million USD | -10.23% |
| 2008 | 5.82 Million USD | -5.06% |
| 2007 | 6.13 Million USD | -21.79% |
| 2006 | 7.84 Million USD | -28.7% |
| 2005 | 11 Million USD | -13.49% |
| 2004 | 12.72 Million USD | -7.43% |
| 2003 | 13.74 Million USD | -8.51% |
| 2002 | 15.02 Million USD | 40.0% |
| 2001 | 10.73 Million USD | -18.11% |
| 2000 | 13.1 Million USD | -6.87% |
| 1999 | 14.07 Million USD | 0.7% |
| 1998 | 13.97 Million USD | 42.6% |
| 1997 | 9.8 Million USD | 326.09% |
| 1996 | 2.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 22.86 Million USD | -25.57% |
| 2024 Q1 | 30.72 Million USD | -2.05% |
| 2023 FY | 31.36 Million USD | -51.76% |
| 2023 Q1 | 51 Million USD | -21.55% |
| 2023 Q2 | 49.87 Million USD | -2.2% |
| 2023 Q4 | 31.36 Million USD | -20.24% |
| 2023 Q3 | 39.32 Million USD | -21.16% |
| 2022 Q1 | 70.35 Million USD | -15.28% |
| 2022 FY | 65.01 Million USD | -21.71% |
| 2022 Q4 | 65.01 Million USD | -14.28% |
| 2022 Q3 | 75.84 Million USD | 29.15% |
| 2022 Q2 | 58.72 Million USD | -16.53% |
| 2021 Q3 | 81.16 Million USD | -13.65% |
| 2021 Q4 | 83.04 Million USD | 2.32% |
| 2021 FY | 83.04 Million USD | -11.11% |
| 2021 Q1 | 92.66 Million USD | -0.81% |
| 2021 Q2 | 93.98 Million USD | 1.43% |
| 2020 Q3 | 104.21 Million USD | -9.23% |
| 2020 Q4 | 93.42 Million USD | -10.36% |
| 2020 Q1 | 119.99 Million USD | -10.74% |
| 2020 FY | 93.42 Million USD | -30.5% |
| 2020 Q2 | 114.81 Million USD | -4.32% |
| 2019 Q2 | 158.64 Million USD | -7.86% |
| 2019 Q3 | 147.27 Million USD | -7.16% |
| 2019 FY | 134.42 Million USD | -27.44% |
| 2019 Q4 | 134.42 Million USD | -8.73% |
| 2019 Q1 | 172.18 Million USD | -7.06% |
| 2018 Q1 | 213.11 Million USD | 69.8% |
| 2018 FY | 185.26 Million USD | 46.19% |
| 2018 Q4 | 185.26 Million USD | -7.67% |
| 2018 Q3 | 200.65 Million USD | -8.06% |
| 2018 Q2 | 218.25 Million USD | 2.41% |
| 2017 Q1 | 74.4 Million USD | -10.2% |
| 2017 Q3 | 136.1 Million USD | -8.2% |
| 2017 Q4 | 125.51 Million USD | -7.78% |
| 2017 FY | 126.72 Million USD | 52.96% |
| 2017 Q2 | 148.25 Million USD | 99.26% |
| 2016 Q2 | 110.51 Million USD | -12.04% |
| 2016 Q4 | 82.85 Million USD | -14.26% |
| 2016 Q3 | 96.63 Million USD | -12.56% |
| 2016 FY | 82.85 Million USD | -40.53% |
| 2016 Q1 | 125.64 Million USD | -9.82% |
| 2015 Q2 | 53.34 Million USD | -15.77% |
| 2015 Q1 | 63.33 Million USD | -9.26% |
| 2015 Q4 | 139.32 Million USD | 211.3% |
| 2015 FY | 139.32 Million USD | 99.6% |
| 2015 Q3 | 44.75 Million USD | -16.11% |
| 2014 FY | 69.8 Million USD | 60.72% |
| 2014 Q1 | 41.41 Million USD | -4.64% |
| 2014 Q3 | 75.15 Million USD | -8.13% |
| 2014 Q4 | 69.8 Million USD | -7.12% |
| 2014 Q2 | 81.8 Million USD | 97.51% |
| 2013 Q2 | 29.33 Million USD | -6.08% |
| 2013 Q3 | 45.93 Million USD | 56.6% |
| 2013 Q4 | 43.43 Million USD | -5.45% |
| 2013 FY | 43.43 Million USD | 152.3% |
| 2013 Q1 | 31.22 Million USD | 134.52% |
| 2012 Q1 | 5.67 Million USD | -5.56% |
| 2012 Q2 | 17.21 Million USD | 203.11% |
| 2012 Q3 | 15.86 Million USD | -7.84% |
| 2012 Q4 | 13.31 Million USD | -16.06% |
| 2012 FY | 17.21 Million USD | 174.79% |
| 2011 Q2 | 6.26 Million USD | -1.49% |
| 2011 FY | 6.26 Million USD | -0.07% |
| 2011 Q1 | 6.35 Million USD | -1.21% |
| 2011 Q3 | 6.25 Million USD | -0.2% |
| 2011 Q4 | 6.01 Million USD | -3.81% |
| 2010 Q1 | 4.5 Million USD | 0.36% |
| 2010 FY | 6.26 Million USD | 19.83% |
| 2010 Q4 | 6.43 Million USD | 0.3% |
| 2010 Q3 | 6.41 Million USD | 2.37% |
| 2010 Q2 | 6.26 Million USD | 39.13% |
| 2009 Q3 | 4.85 Million USD | -7.25% |
| 2009 FY | 5.23 Million USD | -10.23% |
| 2009 Q1 | 5.38 Million USD | -1.56% |
| 2009 Q2 | 5.23 Million USD | -2.81% |
| 2009 Q4 | 4.48 Million USD | -7.48% |
| 2008 Q4 | 5.46 Million USD | -2.48% |
| 2008 Q3 | 5.6 Million USD | -3.79% |
| 2008 Q1 | 5.92 Million USD | 6.34% |
| 2008 Q2 | 5.82 Million USD | -1.63% |
| 2008 FY | 5.82 Million USD | -5.06% |
| 2007 Q4 | 5.57 Million USD | -4.39% |
| 2007 Q2 | 6.13 Million USD | -6.58% |
| 2007 Q3 | 5.82 Million USD | -5.07% |
| 2007 Q1 | 6.57 Million USD | -6.47% |
| 2007 FY | 6.13 Million USD | -21.79% |
| 2006 Q4 | 7.02 Million USD | -4.93% |
| 2006 FY | 7.84 Million USD | -28.7% |
| 2006 Q3 | 7.38 Million USD | -5.85% |
| 2006 Q2 | 7.84 Million USD | -8.36% |
| 2006 Q1 | 8.56 Million USD | -7.8% |
| 2005 Q3 | 10.09 Million USD | -8.31% |
| 2005 Q4 | 9.28 Million USD | -7.97% |
| 2005 Q1 | 11.38 Million USD | -4.57% |
| 2005 FY | 11 Million USD | -13.49% |
| 2005 Q2 | 11 Million USD | -3.28% |
| 2004 Q1 | 12.69 Million USD | -2.55% |
| 2004 FY | 12.72 Million USD | -7.43% |
| 2004 Q4 | 11.92 Million USD | -2.64% |
| 2004 Q2 | 12.72 Million USD | 0.26% |
| 2004 Q3 | 12.24 Million USD | -3.73% |
| 2003 Q4 | 13.02 Million USD | -2.03% |
| 2003 FY | 13.74 Million USD | -8.51% |
| 2003 Q3 | 13.29 Million USD | -3.29% |
| 2003 Q2 | 13.74 Million USD | -2.72% |
| 2003 Q1 | 14.12 Million USD | -3.88% |
| 2002 Q4 | 14.69 Million USD | -1.06% |
| 2002 FY | 15.02 Million USD | 40.0% |
| 2002 Q1 | 14.04 Million USD | 14.14% |
| 2002 Q2 | 15.02 Million USD | 6.96% |
| 2002 Q3 | 14.85 Million USD | -1.11% |
| 2001 Q2 | 10.73 Million USD | -6.63% |
| 2001 Q4 | 12.3 Million USD | 20.02% |
| 2001 FY | 10.73 Million USD | -18.11% |
| 2001 Q3 | 10.25 Million USD | -4.45% |
| 2001 Q1 | 11.49 Million USD | -4.8% |
| 2000 FY | 13.1 Million USD | -6.87% |
| 2000 Q4 | 12.07 Million USD | -5.69% |
| 2000 Q3 | 12.8 Million USD | -2.32% |
| 2000 Q2 | 13.1 Million USD | -0.16% |
| 2000 Q1 | 13.12 Million USD | -6.71% |
| 1999 FY | 14.07 Million USD | 0.7% |
| 1999 Q1 | 14.1 Million USD | 2.03% |
| 1999 Q2 | 14.07 Million USD | -0.2% |
| 1999 Q3 | 13.88 Million USD | -1.3% |
| 1999 Q4 | 14.07 Million USD | 1.31% |
| 1998 Q2 | 13.97 Million USD | -5.89% |
| 1998 Q1 | 14.84 Million USD | 13.86% |
| 1998 Q3 | 13.72 Million USD | -1.76% |
| 1998 Q4 | 13.81 Million USD | 0.67% |
| 1998 FY | 13.97 Million USD | 42.6% |
| 1997 Q3 | 11.42 Million USD | 16.62% |
| 1997 Q2 | 9.8 Million USD | 6.52% |
| 1997 Q1 | 9.2 Million USD | 3.37% |
| 1997 FY | 9.8 Million USD | 326.09% |
| 1997 Q4 | 13.04 Million USD | 14.11% |
| 1996 Q4 | 8.9 Million USD | 229.63% |
| 1996 Q1 | 1.6 Million USD | 33.33% |
| 1996 FY | 2.3 Million USD | 0.0% |
| 1996 Q2 | 2.3 Million USD | 43.75% |
| 1996 Q3 | 2.7 Million USD | 17.39% |
| 1995 Q4 | 1.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| BrainsWay Ltd. | 62.97 Million USD | 50.191% |
| Cerus Corporation | 197.74 Million USD | 84.138% |
| Envoy Medical, Inc. | 7.64 Million USD | -310.55% |
| electroCore, Inc. | 16.38 Million USD | -91.408% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -307.774% |
| IceCure Medical Ltd | 16.41 Million USD | -91.14% |
| Inogen, Inc. | 326.19 Million USD | 90.384% |
| OrthoPediatrics Corp. | 449.58 Million USD | 93.023% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -15.02% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -89.191% |
| MaxCyte, Inc. | 268.27 Million USD | 88.308% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -287.363% |
| Nexalin Technology, Inc. | 3.63 Million USD | -763.621% |
| Orthofix Medical Inc. | 925.31 Million USD | 96.61% |
| PAVmed Inc | 33.11 Million USD | 5.293% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 78.135% |
| RxSight, Inc. | 182.55 Million USD | 82.818% |
| Sight Sciences, Inc. | 166.65 Million USD | 81.179% |
| SI-BONE, Inc. | 230.42 Million USD | 86.388% |
| TELA Bio, Inc. | 78.04 Million USD | 59.812% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 87.549% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -192.321% |
| Acutus Medical, Inc. | 53.96 Million USD | 41.872% |
| Talis Biomedical Corporation | 98.34 Million USD | 68.105% |
| Spectral AI, Inc. | 10.69 Million USD | -193.36% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 85.655% |
| CVRx, Inc. | 115.22 Million USD | 72.779% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 46.53% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -906.852% |
| Bioventus Inc. | 810.91 Million USD | 96.132% |
| Venus Concept Inc. | 93.65 Million USD | 66.509% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -21.928% |
| LivaNova PLC | 2.42 Billion USD | 98.709% |
| 908 Devices Inc. | 202.98 Million USD | 84.547% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 96.105% |
| Nemaura Medical Inc. | 14.56 Million USD | -115.378% |
| NeuroPace, Inc. | 107.65 Million USD | 70.863% |
| LENSAR, Inc. | 69.58 Million USD | 54.924% |
| Apyx Medical Corporation | 79.24 Million USD | 60.416% |
| Cutera, Inc. | 346.29 Million USD | 90.942% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 25.347% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1644.494% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 88.41% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 26.476% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.171% |
| Axonics, Inc. | 719.92 Million USD | 95.643% |
| Outset Medical, Inc. | 313.8 Million USD | 90.004% |
| IRIDEX Corporation | 34.43 Million USD | 8.915% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 92.25% |
| IRadimed Corporation | 92.15 Million USD | 65.964% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -496.993% |
| INVO Bioscience, Inc. | 20.88 Million USD | -50.164% |
| Telesis Bio, Inc. | 70.41 Million USD | 55.453% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 79.646% |
| Varex Imaging Corporation | 1.24 Billion USD | 97.49% |
| Quipt Home Medical Corp. | 247.4 Million USD | 87.322% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -236.907% |
| Pulmonx Corporation | 178.95 Million USD | 82.472% |
| Dynatronics Corporation | 25.94 Million USD | -20.915% |
| Modular Medical, Inc. | 13.8 Million USD | -127.175% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -192.402% |
| Semler Scientific, Inc. | 78.06 Million USD | 59.821% |
| InMode Ltd. | 863.28 Million USD | 96.367% |
| Bruker Corporation | 4.24 Billion USD | 99.262% |
| Cytosorbents Corporation | 53.26 Million USD | 41.108% |
| DexCom, Inc. | 6.26 Billion USD | 99.499% |
| Align Technology, Inc. | 6.08 Billion USD | 99.484% |
| Viveve Medical, Inc. | 25.91 Million USD | -21.043% |
| ZimVie Inc. | 1.2 Billion USD | 97.398% |
| Movano Inc. | 9.42 Million USD | -232.937% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 93.697% |
| Nexalin Technology, Inc. | 3.63 Million USD | -763.621% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 46.53% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 96.708% |
| Profound Medical Corp. | 43.68 Million USD | 28.202% |
| Insulet Corporation | 2.58 Billion USD | 98.788% |
| enVVeno Medical Corporation | 48.63 Million USD | 35.507% |
| Surmodics, Inc. | 185.73 Million USD | 83.112% |
| iCAD, Inc. | 41.41 Million USD | 24.27% |
| Nuwellis, Inc. | 9.77 Million USD | -221.044% |
| Biotricity, Inc. | 5.94 Million USD | -427.814% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 92.759% |
| Aethlon Medical, Inc. | 8.24 Million USD | -280.379% |
| InspireMD, Inc. | 47.64 Million USD | 34.165% |
| PAVmed Inc. | 33.11 Million USD | 5.293% |
| BIOLASE, Inc. | 35.1 Million USD | 10.641% |
| Beyond Air, Inc. | 56.96 Million USD | 44.934% |
| FONAR Corporation | 214.24 Million USD | 85.36% |
| AxoGen, Inc. | 196.82 Million USD | 84.064% |
| Vivani Medical, Inc. | 45.79 Million USD | 31.511% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 88.855% |
| Inari Medical, Inc. | 674.23 Million USD | 95.348% |
| UFP Technologies, Inc. | 404.13 Million USD | 92.239% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -34.051% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -230.06% |
| Tenon Medical, Inc. | 6.34 Million USD | -394.342% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -233.433% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 69.738% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.321% |
| Sintx Technologies, Inc. | 15.36 Million USD | -104.139% |
| NanoVibronix, Inc. | 6.67 Million USD | -369.973% |
| Quanterix Corporation | 425.01 Million USD | 92.62% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -236.907% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 41.62% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.204% |
| TransMedics Group, Inc. | 706.04 Million USD | 95.558% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 50.364% |
| NeuroMetrix, Inc. | 21.42 Million USD | -46.403% |
| Hyperfine, Inc. | 94.19 Million USD | 66.702% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 88.324% |
| Biomerica, Inc. | 9.25 Million USD | -238.945% |
| Bone Biologics Corporation | 3.73 Million USD | -739.165% |
| AVITA Medical, Inc. | 144.33 Million USD | 78.269% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -544.26% |
| Silk Road Medical, Inc | 265.3 Million USD | 88.178% |